Latest Conference Articles

Jesse Wright, MD, PhD, suggests clinicians and patients have a list of triggers and social networks for patients who might be at risk of suicide.

In a virtual APA session, Nora D. Volkow, MD, discusses how vaping can increase the risk of individuals of developing infections from the coronavirus.

An expert projects annual national prevention lifeline calls will reach 3.7 million by 2023.

An analysis of 20-year outpatient prescribing trends show the drug class is being favored over mood stabilizers.

A look at the 3 stages of alcohol abuse and the state of mental health throughout it.

A look at how the antibody influences the pathology of encephalitis, and how it can be properly assessed and treated.

New research shows case fatality rates are increasing for individuals between 20-44 years old.

New federal regulations allows psychiatrists to use popular video conferencing tools like Zoom for telehealth appointments.

Investigators are still looking into the immediate and longterm effects of the virus on the mind.

In a presentation for the American Psychiatric Association, Elinore McCance-Katz says helpline calls have dramatically increased since the COVID-19 pandemic.

Substance use is common in as many as 10% of pregnant women in the US. What are the risks of each substances, and what are the proven methods of treatment?

How do comorbidities influence patients' life expectancies? What is the role of public health programs?

Why the field lacks behind in effective diagnostic tools, which could better inform tailored therapy.

The novel target therapy has reported promising early findings. What is its potential?

In a presentation at the APA Spring Highlights Meeting 2020, Patrice Harris, MD, says telemedicine is crucial to maintain care while decreasing the risk of COVID-19.

How have natural-cause mortality rates changed over time in an international population?

How psychiatry can catch up to other specialties in accurate, timely diagnostics based on molecular breakthrough.

It might be particularly difficult for psychiatrists to treat trauma patients through telehealth means.

SEP-363856 is showing initial efficacy and long-term safety in adult patients.

David Jiang, MD, explains some preffered therapies and medications for trauma patients.

Data regarding major adverse events remain unreliable due to a lack of a patient registry.

A public health expert shares insight on the positives and pitfalls learned from stigma-reduction campaigns.

A discussion on how difficulties accepting the drug addiction public health crisis is affecting the rate of care-seeking patients.

Discussing research related to TAVR with a cardiac surgeon from Brigham and Women's Hospital.

Discussing takeaways from the late-breaking abstracts related to TAVR presented at ACC.20/WCC with a cardiac surgeon from Brigham and Women's Hospital.

The latest piece coming to us through Notes from Rounds examines how the timing of hormone replacement therapy can impact potential for adverse outcomes.

How do e-cigarettes fit into the cardiovascular health paradigm? What more needs to be learned?

New findings show the addition of easily identified circulating proteins can provide a more accurate risk assessment.